This observational study uses registry data to compare rates of adverse functional outcomes between specific treatments for localized prostate cancer (radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance for favorable-prognosis disease and radical prostatectomy or external beam radiotherapy with androgen deprivation therapy for unfavorable-prognosis disease).